Homeopathy as a Therapeutic Option in Space

Summary: COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse.

Download Full-text

Endovascular repair of a spontaneous ilio-iliac fistula presenting as pulmonary embolism

VASA ◽

10.1024/0301-1526/a000100 ◽

2011 ◽

Vol 40 (3) ◽

pp. 246-250 ◽

Cited By ~ 4

Author(s):

Melas ◽

Saratzis ◽

Abbas ◽

Sarris ◽

Saratzis ◽

...

Keyword(s):

Pulmonary Embolism ◽

Endovascular Repair ◽

Therapeutic Option ◽

Artery Aneurysm ◽

Iliac Vein ◽

Massive Pulmonary Embolism ◽

Long Term Results ◽

Common Iliac Vein ◽

Iliac Artery Aneurysm ◽

Common Iliac Artery Aneurysm

Spontaneous rupture of a common iliac artery aneurysm into the common iliac vein is a rare phenomenon. We report the case of a 68 year old man admitted with acute cardiac failure and massive pulmonary embolism as a complication of a spontaneous ilio-iliac fistula, secondary to aneurysmal rupture. The aneurysm was successfully excluded using an aorto-uni-iliac stent graft. No complications were noted at 9 months follow-up. Arteriovenous fistulae should be considered in patients with aortic or iliac aneurysms who develop a pulmonary embolism or symptoms of venous congestion. Endovascular repair of these pathologies is a feasible therapeutic option; however long term results remain unknown.

Download Full-text

Auricular vagal nerve stimulation in peripheral arterial disease patients

VASA ◽

10.1024/0301-1526/a000660 ◽

2017 ◽

Vol 46 (6) ◽

pp. 462-470 ◽

Cited By ~ 3

Author(s):

Gerald Hackl ◽

Andreas Prenner ◽

Philipp Jud ◽

Franz Hafner ◽

Peter Rief ◽

...

Keyword(s):

Primary Endpoint ◽

Nerve Stimulation ◽

Short Form ◽

Therapeutic Option ◽

Arterial Disease ◽

Walking Distance ◽

Control Group ◽

Sf 36 ◽

Peripheral Arterial ◽

Double Blinded

Abstract. Background: Auricular nerve stimulation has been proven effective in different diseases. We investigated if a conservative therapeutic alternative for claudication in peripheral arterial occlusive disease (PAD) via electroacupuncture of the outer ear can be established. Patients and methods: In this prospective, double-blinded trial an ear acupuncture using an electroacupuncture device was carried out in 40 PAD patients in Fontaine stage IIb. Twenty patients were randomized to the verum group using a fully functional electroacupuncture device, the other 20 patients received a sham device (control group). Per patient, eight cycles (1 cycle = 1 week) of electroacupuncture were performed. The primary endpoint was defined as a significantly more frequent doubling of the absolute walking distance after eight cycles in the verum group compared to controls in a standardized treadmill testing. Secondary endpoints were a significant improvement of the total score of the Walking Impairment Questionnaire (WIQ) as well as improvements in health related quality of life using the Short Form 36 Health Survey (SF-36). Results: There were no differences in baseline characteristics between the two groups. The initial walking distance significantly increased in both groups (verum group [means]: 182 [95 % CI 128–236] meters to 345 [95 % CI 227–463] meters [+ 90 %], p < 0.01; control group [means]: 159 [95 % CI 109–210] meters to 268 [95 % CI 182–366] meters [+ 69 %], p = 0.01). Twelve patients (60 %) in the verum group and five patients (25 %) in controls reached the primary endpoint of doubling walking distance (p = 0.05). The total score of WIQ significantly improved in the verum group (+ 22 %, p = 0.01) but not in controls (+ 8 %, p = 0.56). SF-36 showed significantly improvements in six out of eight categories in the verum group and only in one of eight in controls. Conclusions: Electroacupuncture of the outer ear seems to be an easy-to-use therapeutic option in an age of increasingly invasive and mechanically complex treatments for PAD patients.

Download Full-text

Adult-to-Adult Living-Donor Liver Transplantation

Swiss Surgery ◽

10.1024/1023-9332.9.5.227 ◽

2003 ◽

Vol 9 (5) ◽

pp. 227-236 ◽

Cited By ~ 3

Author(s):

Majno ◽

Mentha ◽

Berney ◽

Bühler ◽

Giostra ◽

...

Keyword(s):

Liver Transplantation ◽

Living Donor ◽

Living Donor Liver Transplantation ◽

Therapeutic Option ◽

Donor Liver ◽

Donor Liver Transplantation ◽

Multidisciplinary Program ◽

First Case ◽

Living Donor Transplantation ◽

The Right

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.

Download Full-text

Sorafenib as a new therapeutic option for Hepatoblastoma

Klinische Pädiatrie ◽

10.1055/s-0031-1277083 ◽

2011 ◽

Vol 223 (03) ◽

Author(s):

A Dewerth ◽

C Eicher ◽

J Fuchs ◽

S Armeanu-Ebinger

Keyword(s):

Therapeutic Option

Download Full-text

Glatiramer Acetate As a Therapeutic Option in Relapsing Optic Neuritis, MOG-, and NMO-IgG-Seronegative

Neuropediatrics ◽

10.1055/s-0034-1390654 ◽

2014 ◽

Vol 45 (S 01) ◽

Author(s):

C. Thiels ◽

I. Kleiter ◽

K. Weigt-Usinger ◽

A. Salmen ◽

C. Köhler ◽

...

Keyword(s):

Optic Neuritis ◽

Glatiramer Acetate ◽

Therapeutic Option

Download Full-text

Targeting IAPs in childhood ALL – a promising therapeutic option?

10.1055/s-0037-1602190 ◽

2017 ◽

Author(s):

J Zinngrebe ◽

M Meyer ◽

KM Debatin ◽

LH Meyer

Keyword(s):

Therapeutic Option ◽

Childhood All

Download Full-text

Biological implants as therapeutic option for mid and distal arch stenosis in children

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-2006-925687 ◽

2006 ◽

Vol 54 (S 1) ◽

Author(s):

L Ben Mime ◽

R Raji ◽

K Hekmat ◽

N Sreeram ◽

K Brockmeier ◽

...

Keyword(s):

Therapeutic Option ◽

Biological Implants

Download Full-text

Levosimendan: a therapeutic option in the primary graft failure after heart transplantation

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-2008-1037815 ◽

2008 ◽

Vol 56 (S 1) ◽

Author(s):

A Beiras-Fernandez ◽

F Weis ◽

I Kaczmarek ◽

F Kur ◽

M Weis ◽

...

Keyword(s):

Heart Transplantation ◽

Graft Failure ◽

Therapeutic Option ◽

Primary Graft Failure

Download Full-text

Off-Pump Supraarterial Decompression Myotomy for Myocardial Bridging

The Heart Surgery Forum ◽

10.1532/hsf98.20041116 ◽

2005 ◽

Vol 8 (1) ◽

pp. 49 ◽

Cited By ~ 7

Author(s):

Mersa M. Baryalei ◽

Theodorus Tirilomis ◽

Wolfgang Buhre ◽

Stephan Kazmaier ◽

Friedrich A. Schoendube ◽

...

Keyword(s):

Myocardial Infarction ◽

Exercise Testing ◽

Clinical Symptoms ◽

Therapeutic Option ◽

Median Sternotomy ◽

Myocardial Bridging ◽

Off Pump ◽

Hemodynamic Compromise ◽

Artery Disease ◽

The Right

Background: Myocardial bridging of the left anterior descending (LAD) artery may result in clinical symptoms. Surgery with cardiopulmonary bypass (CPB) is a therapeutic option with considerable risk. We hypothesized that off-pump supraarterial myotomy could be an effective treatment modality. Methods: Between October 1998 and May 2000, 13 patients were referred for surgery. All were symptomatic despite medical therapy. Anteroseptal ischemia had been proven by thallium scintigraphy in all 13 patients, exercise testing was positive in 11. All patients were operated on with an off-pump approach after median sternotomy. Results: Mean patient age was 61 8 years (range, 43-71 years). Coronary artery disease mandating additional bypasses was present in 3 patients. The bypasses were done off pump in 2 patients. Conversion to on-pump surgery was necessary in 3 of 13 patients (23%) because of hemodynamic compromise (1 patient), opening of the right ventricle (1 patient), and injury to the LAD (1 patient). Supraarterial myotomy was performed in all patients. One patient who underwent surgery with CPB developed postoperative anteroseptal myocardial infarction. Postoperative exercise testing was performed in all patients and did not reveal any persistent ischemia. Mortality was 0%. All patients were free from symptoms and had not undergone repeat interventions after an average of 51 7 months of follow-up. Conclusions: Off-pump supraarterial myotomy effectively relieves coronary obstruction but has a certain periprocedural risk as evidenced by 1 myocardial infarction, 1 right ventricular injury, and 1 LAD injury. Long-term freedom from symptoms and from reintervention favor further investigation of this surgical therapy.

Download Full-text